Downstream Processing Featured Articles

71. Targeting Sugars In The Quest For A Vaccine Against HIV — The Virus That Causes AIDS 8/21/2012

    As a step toward designing the first effective vaccine against HIV, the virus that causes AIDS, scientists are reporting new insights into how a family of rare, highly potent antibodies bind to HIV and neutralize it — stop it from infecting human cells. 

72. Rockland Immunochemicals Acquires TrueBlot Product Line 12/13/2012

    Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development, and preclinical studies, recently announced the acquisition of the TrueBlot IP/Western blot product line from eBioscience, Inc., an Affymetrix company.

73. A Class Of RNA Molecules Protects Germ Cells From Damage, Penn Vet Researchers Show 11/15/2012

    Passing one’s genes on to the next generation is a mark of evolutionary success. So it makes sense that the body would work to ensure that the genes the next generation inherits are exact replicas of the originals.

74. WHO Member States Make Progress On Noncommunicable Diseases 11/12/2012

    The first-ever global monitoring framework to combat several of the world’s biggest killers has been agreed this week by WHO Member States. The framework comprises nine voluntary global targets and 25 indicators to prevent and control diseases such as heart disease, diabetes, cancer, chronic lung disease and other noncommunicable diseases.

75. AB SCIEX And Indigo Team Up To Accelerate Adoption Of Next-Generation Mass Spectrometry For Clinical Research, Forensic Toxicology And Clinical Trials 1/18/2012
    AB SCIEX and Indigo BioSystems recently announced an agreement to jointly market mass spectrometry solutions that streamline data acquisition and automate data review to ensure high quality results in clinical research and forensic toxicology as well as pre-clinical and clinical trials of new drugs.
76. Roche Receives FDA Clearance For Herpes Simplex Virus Type 1 And 2 Tests 9/4/2012

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 assays for use on cobas® modular platforms. The tests are intended for use with sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV-1 and HSV-2 infection. 

77. Merck Champions Single-Use By Addressing Emotion Vs. Science 3/2/2015

    Lowering the cost of medication is the key to the US gaining a stronghold on the global pharmaceutical market. As anyone knows, in order to lower the cost of medication, the cost of manufacturing will need to be lowered as well. According to Chris Smalley, Ph.D., director of validation compliance at Merck, single-use technology (SUT) could be the hero. 

78. Standardized Extractables Testing Advances Single Use Adoption 6/3/2015

    The Standardized Extractables Testing Protocol For Single-Use Systems In Biomanufacturing written by BPOG members last year establishes a foundation from which to create a standardized approach to extractables testing. However, since its release, there have been some questions and discussions about how to effectively implement the protocol.

79. Sunshine Biopharma Initiates IND-Enabling Studies For Its Anticancer Compound, Adva-27a 11/13/2012

    Sunshine Biopharma Inc. (OTCBB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has initiated the IND-Enabling studies for Adva-27a, the Company's flagship oncology drug candidate.

80. Injection-Free Vaccination 2/5/2013

    Injection-free vaccination technique could address global vaccine challenge for diseases such as HIV and malaria